Wakefit Innovations Limited DCF Valuation

WAKEFIT · Consumer Durables · Current price ₹135.53

Full stock page
DocStoX fair value
₹214
high confidence · 70/100
Current price
₹155
Upside to fair value
+37.9%
Estimate range
₹192 – ₹235
5Y profit growth
—
Model it yourself — DCF Calculator
Opens pre-filled with Wakefit Innovations Limited's latest numbers.

Wakefit Innovations Limited cash-flow valuation

Our engine did not use a discounted-cash-flow model for Wakefit Innovations Limited. It routes each business to the methods that suit it, and a DCF is a poor lens where cash-flow forecasts are fragile or the business is capital-structure driven. The methods it did use, and why, are set out below. Our published estimate is ₹214.

Try your own assumptions

Prefer to build the discounted cash flow yourself? The DCF calculator below opens pre-filled with Wakefit Innovations Limited's reported free cash flow, net debt and share count, so you can set your own growth and discount rate.

How we got this fair value

Every number below is part of the same estimate for Wakefit Innovations Limited. Nothing here is a target price or a forecast of where the share price will go.

High confidence70/100

The models agree and the inputs are well covered. Treat this as our firmest estimate.

Estimate range ₹192 – ₹235

Why this method for this business

Wakefit is an asset-light consumer durables brand with a durable moat. Relative P/E and PEG are appropriate for valuing its earnings power and growth potential.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Fair multiple (P/E)
₹21470% weight
PEG (growth-implied P/E)(not enough data)

required inputs missing

  • dcf: Not suitable for a consumer brand with erratic earnings and no clear cash flow patterns
  • peg: Limited data on growth rates and peer comparisons

What was missing

  • Limited historical P/E data for the company
  • Uncertainty around long-term growth rates

What drives it

14 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
Sector-median P/E
35.04×

peer-median

Peers used
9

peer-median

EPS (TTM)
6.38 ₹/share

computed

JudgementOur read of the evidence, not a measurement.
Term: quality
-14.1%

quality 27/100 (weak/erratic returns) → discount

Term: growth
+6.7%

durable ~15% CAGR (ROCE -2% < 12% hurdle (growth not value-accretive)) → premium

Term: capital_allocation
-1.5%

capital allocation: steady → neutral

Term: financial_strength
+4.5%

financial strength: low leverage (D/E 0.2) → mild premium

Term: history
+0.0%

history: no reliable own-history P/E → not used

Term: sector_rerating
+0.0%

sector re-rating: no sector-norm history → not used

Term: rate_regime
+1.2%

rates: risk-free 6.9% below ~7.1% normal → higher multiple

Term: risk
+0.0%

risk: no analyst-dispersion signal available → neutral (lowers confidence, not PE)

DerivedFalls out of the inputs above: a model output, not an independent input.
Premium vs sector
-4.4%

fundamentals + macro (not capped at own history)

Fair-multiple confidence
45%

data completeness + term agreement

Fair P/E
33.49×

sector median × ∏(1+term) — Dynamic Fair Multiple

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Wakefit Innovations Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 15 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on Wakefit Innovations Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.